In addition, electrophilic modifiers of Keap1 and inhibitors of its interaction with NRF2 could also be novel therapeutic targets [117] Other ROS scavengers, including metal-base antioxidants, can move the redox balance to its original levels and thereby inhibit cancer cell growth [118]. This evidence concerns the gene KEAP1 and cancer.